CV conditions and treatments

(141) A Cross-Sectional Observational Study to Assess Treatment Awareness, Prescription Pattern and Adverse Drug Reactions of Secondary Prophylactic Drug Treatment in Patients of Stroke visiting a Tertiary Care Hospital.

(142) A multi-country, observational study of high-risk pre-event cardiovascular patients: design and analytical framework

(143) A Population-Based Assessment of the Use of Oral Anticoagulants and the Risk of Major Bleeding Among Patients with Non-Valvular Atrial Fibrillation Treated With Antiarrhythmics

(144) A scoping Review of Factors Associated with the Prescribing of Direct Oral Anticoagulant Drugs (DOACs)

(145) Acute cardiovascular adverse effects associated with the use of prescription medications: A Danish nationwide screening study

(146) An Electronic Health Record Analysis Studying Differences in Medication Use Associated with Renal Impairment in Acute Heart Failure

(148) Association between incident interstitial lung disease with direct oral anticoagulants compared to warfarin users: Multi-database cohort study

(149) Characteristics Associated with Long-Term Glucocorticoid Use in Patients with New Onset Polymyalgia Rheumatica

(150) Associations between β-adrenoreceptors agonists and antagonists and Parkinson’s disease: systematic review and meta-analysis

(151) Case Study With a Cardiovascular Outcomes Trial for a Glucagon-Like Peptide-1 Receptor Agonist: Evaluating Trial Generalizability With an Enriched Electronic Health Record-Based Database

(152) Characterizing Patients with Postural Orthostatic Tachycardia Syndrome (POTS) in Claims Data After the Introduction of a Specific Diagnosis Code

(154) Comparative cardiovascular safety evaluation of long- vs short-acting erythropoiesis-stimulating agents (ESA) in chronic kidney disease patients: a meta-analysis and signal detection using the FDA Adverse Event Reporting System

(155) Comparative effectiveness and prescribing trends of modified-release versus immediate-release indapamide in patients with hypertension: a cohort study in the UK

(156) Comparative Effectiveness and Safety of High-Intensity Statin Monotherapy vs. Combination Therapy with Ezetimibe in Post-ACS Lipid Management in Asian Patients: An Observational Cohort Study in Taiwan

(157) Comparative effectiveness of anti-hyperlipidemic drugs monotherapy in primary prevention of cardiovascular disease

(158) Comparative Effectiveness of ARB and ACEi for Cardiovascular Outcomes and Risk of Angioedema by Ethnicity: an Analysis in the UK Clinical Practice Research Datalink with Emulation of a Reference Trial (ONTARGET)

(159) Comparison of rates of myocardial infarction and stroke for patients with type 2 diabetes 2005 versus 2015

(160) Cost-Effectiveness of Statins in the Primary Prevention of Cardiovascular Disease in Older Adults: A 5-Year Retrospective Cohort Study

(161) DARWIN EU® - Real-World Evaluation of Pulmonary Arterial Hypertension Treatment and Outcomes in Europe

(162) Decreased Hazard of Potassium Lowering Drug Prescription Receipt Following Implementation of the 2021 CKD-EPI Creatinine GFR Equation

(163) Disseminated Intravascular Coagulation after idarucizumab or andexanet alfa: a disproportional analysis and case-by-case analysis of reports from the FAERS database

(164) Early identification of the association between rofecoxib and cardiovascular adverse events using real-world data from the UK: A case-control study

(165) Effectiveness of early versus delayed post-discharge sodium-glucose cotransporter-2 inhibitor initiation in acute heart failure with type 2 diabetes: a population-based cohort study

(166) Effectiveness, Safety, and Mortality of Cilostazol versus Clopidogrel in East Asian Patients with Ischemic Stroke and Transient Ischemic Attack

(167) Evaluating Algorithms for Sinus Node Dysfunction in US Health Insurance Claims Databases

(168) Evaluating the Cardiovascular Safety of Naltrexone/Bupropion in the United States

(169) Exploration of Reason Codes in Real World Cardiovascular System Short-term Disability Claims in the United States

(170) FACTOR XA INHIBITOR–RELATED MAJOR BLEEDING EVENTS IN THE NETHERLANDS

(171) Factors Associated with Reinitiation and Subsequent Discontinuation of Antiplatelet Medication in Patients with Peripheral Arterial Disease

(172) Feasibility Assessment of Hypertension among Patients with Diabetic Macular Edema using Real World Data

(173) Identifying and profiling patients with heart failure in a population-based cohort through linkage of primary and secondary care data

(176) Incidence of Heat-Related Illness in the United States: A Retrospective Cohort Study Using the PharMetrics® Plus for Academics Dataset, 2017-2022

(178) Lasso Logistic Regression and Cluster Analysis in Predicting Adherence and Drug Patterns among New Users of Monotherapy for Antihypertensive Drugs: a long-term inception cohort study

(179) Low-density Lipoprotein Measurement During and After Hospitalization with Myocardial Infarction in Denmark from 2018 to 2021.

(180) Mapping of Knowledge, Attitude & Practice in Patients Toward Cardiovascular Disorders Attending Out-Patient Department of Cardiology in a Tertiary Care Hospital

(181) Medication adherence and its association with blood pressure control at a teaching hospital in Ghana

(182) Oral anticoagulant prescription trends and adherence among patients with atrial fibrillation and mitral stenosis in Hong Kong

(183) Outcomes of antiarrythmic drugs versus catheter ablation for treatment of atrial fibrillation in an elderly population

(184) Patterns and Determinants of Adherence to Medication Guideline in Myocardial Infarction (MI) Survivors: A Retrospective Cohort Study of 21,510 patients

(185) Predicting Findings of Two On-Going Phase IV Randomized Trials of Direct Oral Anticoagulants: An RCT-DUPLICATE Study.

(186) Real-World Patient Profiles and Lipid-Lowering Efficacy of PCSK9 Inhibitors

(187) Real-World Safety and Effectiveness of Evolocumab in Primary Hypercholesterolemia and Mixed Dyslipidemia in Saudi Arabia

(188) Renal outcomes of cyclooxygenase-2 inhibitor anti-inflammatories: a systematic review and meta-analysis

(189) Risk identification based on prescribed drugs and comorbidities in patients with Torsade de pointes arrhythmia – a population-based Swedish cohort study.

(190) Risk of Lung Cancer With Concomitant Use of Angiotensin Converting Enzyme Inhibitors and Dipeptidyl Peptidase 4 Inhibitors: Population Based Cohort Study

(191) Sex differences in dispensed cardiovascular medication in primary care

(192) Shifting Patterns in Statin Intensity During Post-Acute Coronary Syndrome Period: An Nationwide Observational Study in Taiwan

(193) Temporal Trends In The Dispensing Of Anti-Hypertensive Medications In Ireland And The United Kingdom From 2017-2023

(194) The Impact of National Volume-Based Procurement Program Implementation on Medical Expenditures in China: A Population-based Study of 1.17 Million Hypertensive Patients

(195) The use of Gastroprotective Agents in Patients with Atrial Fibrillation Initiating Direct Oral Anticoagulants

(196) Use of SGLT2 Inhibitors in Patients With Type 2 Diabetes and Chronic Kidney Disease – a Multi-Country Report from the FOUNTAIN Platform

(197) Using negative control outcomes in trial emulation to assess the comparability of patients initiating proprotein convertase subtilisin/kexin type 9 inhibitor monoclonal antibodies following myocardial infarction

(198) Utilisation Patterns and Trends of Statins in Kuwait from 2012 to 2022: A Population-Based Study